{"url_path":"/sec/isco/8-k/2026-06-12/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1355790/0001683168-26-004786-index.html","accession_number":"0001683168-26-004786","cik":"0001355790","ticker":"ISCO","issuer_name":"International Stem Cell CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1355790/0001683168-26-004786-index.html","primary_entity_key":"0001355790","primary_entity_name":"International Stem Cell CORP"},"word_count":181,"has_tables":true,"body_markdown":"**ITEM 5.07 Submission of Matters to a Vote of Security\nHolders**\n\n \n\nInternational Stem Cell Corporation (the “Company”)\nheld its Annual Meeting of Stockholders on June 11, 2026. The stockholders considered one proposal, which is described in more detail\nin the Company’s definitive proxy statement dated April 24, 2026.\n\n \n\n**Proposal 1:**\nElection of four directors to hold office until the 2027 Annual Meeting:\n\n \n\n \nA.\nDirectors elected by holders of Series D Preferred Stock:\n\n \n\n \n**FOR**\n \n**WITHHELD**\n \n\nAndrey Semechkin\n2,457,143\n \n0\n \n\nRussell Kern\n2,457,143\n \n0\n \n\n  \n\n \nB.\nDirectors elected by holders of all shares of stock (including shares of preferred stock voting on an as-converted basis):\n\n \n\n \n**FOR**\n \n**WITHHELD**\n \n\nDonald A. Wright\n9,288,444\n \n30,590\n \n\nPaul V. Maier\n9,288,500\n \n30,534\n \n\n \n\nBroker Non-Votes: none\n\n \n\nAll of the foregoing candidates were elected.\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n 2 \n\n \n\n \n\n**SIGNATURES**\n\n \n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n**INTERNATIONAL STEM CELL CORPORATION**\n\n \n \n \n\n \n \n \n\nDate: June 12, 2026\nBy:\n/s/ Russell Kern\n\n \n \nRussell Kern\n\n \n \n\nExecutive Vice President,\n\nChief Scientific Officer and\n\nPrincipal Financial Officer\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n 3"}